Skip to Content
Search Menu

Jyvässolut saattavat heikentää immuunivastetta COVID-19-taudissa

Selvitimme LDG-solujen roolia akuutissa COVID-19:ssä. Havaitsimme, että ne ovat pääasiassa granulosyyttien esiasteita, joiden määrä lisääntyy erityisesti sairaalahoitoisessa COVID-19 tautimuodossa. Ne saattavat heikentää hankittua immuniteettia.

Get access

If you are a doctor or other health professional, you can access the entire article by creating a profile on BestPractice Nordic.

Asiaan liittyvä sisältö

Latika Gupta

COVID-19 Infection is a Risk Factor for Causing Flares in Autoimmune Rheumatic Diseases Patients

/ Latika Gupta
COVID-19 Play the Video 6:07

Immunosuppressed Patients with Immune-Mediated Inflammatory Diseases Benefit from High Post-Vaccination Antibody Levels Against COVID-19 

/ BestPractice Nordic
COVID-19SCR23

Environmental factors and autoimmune diseases – a hypothesis

/ Henrik Nielsen / Merete Engelhart
COVID-19Inflammatory diseaseRheumatoid arthritis

Oceanic Influence Suppresses COVID-19 Incidence

/ Karin Ebert / Renate Houts / Sergio Noce
COVID-19

Oceanic Influence Suppresses COVID-19 Incidence

/ Karin Ebert / Renate Houts / Sergio Noce
COVID-19

Neutralization titers against SARS-CoV-2 in vaccinated health-care workers

/ Christina Sølund / Alexander James Paul Underwood / Jens Bukh / Nina Weis
COVID-19Vaccination

Neutralization titers against SARS-CoV-2 in vaccinated health-care workers

/ Christina Sølund / Alexander James Paul Underwood / Jens Bukh / Nina Weis
COVID-19
Maria Antonietta D'Agostino

COVID-19 and the future management of patients with rheumatological disorders

/ Maria-Antonietta D'Agostino
COVID-19EULAR22 Play the Video 4:09

Environmental factors and autoimmune diseases – a hypothesis

/ Henrik Nielsen / Merete Engelhart
COVID-19
Back to top